| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | E-box binding | 9.92e-08 | 61 | 124 | 7 | GO:0070888 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ANKRD13B ATG16L1 RIPK1 OFD1 PPRC1 IKBKG ABT1 EMILIN1 NLRP6 SPTBN4 TCHH G3BP1 MYH14 HGS GIGYF2 TRAF3IP3 TNNT2 GCN1 PBXIP1 ZNF433 CUX1 | 8.87e-05 | 1356 | 124 | 21 | GO:0060090 |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 3.78e-04 | 5 | 124 | 2 | GO:0098640 | |
| Domain | - | 3.19e-08 | 109 | 119 | 9 | 4.10.280.10 | |
| Domain | HLH | 3.74e-08 | 111 | 119 | 9 | PF00010 | |
| Domain | HLH | 5.49e-08 | 116 | 119 | 9 | SM00353 | |
| Domain | BHLH | 5.92e-08 | 117 | 119 | 9 | PS50888 | |
| Domain | bHLH_dom | 6.37e-08 | 118 | 119 | 9 | IPR011598 | |
| Domain | MITF_TFEB_C_3_N | 2.52e-07 | 3 | 119 | 3 | PF15951 | |
| Domain | MiT/TFE_N | 2.52e-07 | 3 | 119 | 3 | IPR031867 | |
| Domain | DUF3371 | 1.00e-06 | 4 | 119 | 3 | PF11851 | |
| Domain | MiT/TFE_C | 1.00e-06 | 4 | 119 | 3 | IPR021802 | |
| Domain | DUF3669_Znf | 4.97e-06 | 6 | 119 | 3 | IPR022137 | |
| Domain | DUF3669 | 4.97e-06 | 6 | 119 | 3 | PF12417 | |
| Domain | PH | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 | 1.61e-05 | 229 | 119 | 9 | PF00169 |
| Domain | PH | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 | 7.31e-05 | 278 | 119 | 9 | SM00233 |
| Domain | PH_DOMAIN | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 | 7.51e-05 | 279 | 119 | 9 | PS50003 |
| Domain | PH_domain | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 | 7.72e-05 | 280 | 119 | 9 | IPR001849 |
| Domain | CH | 8.39e-05 | 70 | 119 | 5 | PF00307 | |
| Domain | CH | 1.03e-04 | 73 | 119 | 5 | PS50021 | |
| Domain | CH-domain | 1.17e-04 | 75 | 119 | 5 | IPR001715 | |
| Domain | ZF_CCHC_NOA | 1.20e-04 | 3 | 119 | 2 | PS51801 | |
| Domain | - | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 HOMER3 | 2.02e-04 | 391 | 119 | 10 | 2.30.29.30 |
| Domain | - | 3.08e-04 | 21 | 119 | 3 | 1.10.720.30 | |
| Domain | SAP | 3.56e-04 | 22 | 119 | 3 | PF02037 | |
| Domain | Anaphylatoxin_comp_syst | 3.98e-04 | 5 | 119 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.98e-04 | 5 | 119 | 2 | IPR001840 | |
| Domain | PH_dom-like | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 HOMER3 | 4.00e-04 | 426 | 119 | 10 | IPR011993 |
| Domain | SAP | 4.07e-04 | 23 | 119 | 3 | SM00513 | |
| Domain | SAP | 5.24e-04 | 25 | 119 | 3 | PS50800 | |
| Domain | SAP_dom | 5.24e-04 | 25 | 119 | 3 | IPR003034 | |
| Domain | - | 5.94e-04 | 6 | 119 | 2 | 3.90.1290.10 | |
| Domain | RRM | 6.83e-04 | 230 | 119 | 7 | PS50102 | |
| Domain | CH | 7.86e-04 | 65 | 119 | 4 | SM00033 | |
| Domain | Spectrin_repeat | 8.17e-04 | 29 | 119 | 3 | IPR002017 | |
| Domain | ANATO | 8.28e-04 | 7 | 119 | 2 | SM00104 | |
| Domain | Plectin_repeat | 8.28e-04 | 7 | 119 | 2 | IPR001101 | |
| Domain | ANATO | 8.28e-04 | 7 | 119 | 2 | PF01821 | |
| Domain | Plectin | 8.28e-04 | 7 | 119 | 2 | PF00681 | |
| Domain | DUF3585 | 8.28e-04 | 7 | 119 | 2 | IPR022735 | |
| Domain | ANAPHYLATOXIN_2 | 8.28e-04 | 7 | 119 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 8.28e-04 | 7 | 119 | 2 | PS01177 | |
| Domain | DUF3585 | 8.28e-04 | 7 | 119 | 2 | PF12130 | |
| Domain | Anaphylatoxin/fibulin | 8.28e-04 | 7 | 119 | 2 | IPR000020 | |
| Domain | PLEC | 8.28e-04 | 7 | 119 | 2 | SM00250 | |
| Domain | - | 9.66e-04 | 244 | 119 | 7 | 3.30.70.330 | |
| Domain | Spectrin/alpha-actinin | 1.09e-03 | 32 | 119 | 3 | IPR018159 | |
| Domain | SPEC | 1.09e-03 | 32 | 119 | 3 | SM00150 | |
| Domain | - | 1.10e-03 | 71 | 119 | 4 | 1.10.418.10 | |
| Domain | Thiol-ester_cl | 1.10e-03 | 8 | 119 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.10e-03 | 8 | 119 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 1.10e-03 | 8 | 119 | 2 | IPR019742 | |
| Domain | Nucleotide-bd_a/b_plait | 1.33e-03 | 258 | 119 | 7 | IPR012677 | |
| Domain | ZF_CCHC | 1.42e-03 | 35 | 119 | 3 | PS50158 | |
| Domain | A2M_N | 1.75e-03 | 10 | 119 | 2 | PF01835 | |
| Domain | A2M_N | 1.75e-03 | 10 | 119 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.75e-03 | 10 | 119 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.75e-03 | 10 | 119 | 2 | PS00477 | |
| Domain | A2M | 1.75e-03 | 10 | 119 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.75e-03 | 10 | 119 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.75e-03 | 10 | 119 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.75e-03 | 10 | 119 | 2 | PF07703 | |
| Domain | A2M_recep | 1.75e-03 | 10 | 119 | 2 | PF07677 | |
| Domain | A2M_comp | 1.75e-03 | 10 | 119 | 2 | PF07678 | |
| Domain | PTX | 1.75e-03 | 10 | 119 | 2 | SM00159 | |
| Domain | Macroglobln_a2 | 1.75e-03 | 10 | 119 | 2 | IPR001599 | |
| Domain | Pentaxin-related | 2.13e-03 | 11 | 119 | 2 | IPR001759 | |
| Domain | NTP_transf_2 | 2.13e-03 | 11 | 119 | 2 | PF01909 | |
| Domain | Pentaxin | 2.13e-03 | 11 | 119 | 2 | PF00354 | |
| Domain | Polymerase_NTP_transf_dom | 2.13e-03 | 11 | 119 | 2 | IPR002934 | |
| Domain | RRM_1 | 2.17e-03 | 208 | 119 | 6 | PF00076 | |
| Domain | RRM | 2.68e-03 | 217 | 119 | 6 | SM00360 | |
| Domain | Galactose-bd-like | 3.07e-03 | 94 | 119 | 4 | IPR008979 | |
| Domain | RRM_dom | 3.35e-03 | 227 | 119 | 6 | IPR000504 | |
| Domain | Laminin_N | 4.56e-03 | 16 | 119 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 4.56e-03 | 16 | 119 | 2 | PS51117 | |
| Domain | Laminin_N | 4.56e-03 | 16 | 119 | 2 | PF00055 | |
| Domain | LamNT | 4.56e-03 | 16 | 119 | 2 | SM00136 | |
| Domain | C345C | 5.14e-03 | 17 | 119 | 2 | SM00643 | |
| Domain | ZnF_C2HC | 5.20e-03 | 55 | 119 | 3 | SM00343 | |
| Domain | Znf_CCHC | 5.20e-03 | 55 | 119 | 3 | IPR001878 | |
| Domain | UIM | 5.76e-03 | 18 | 119 | 2 | PF02809 | |
| Domain | Myosin_tail_1 | 5.76e-03 | 18 | 119 | 2 | PF01576 | |
| Domain | Myosin_tail | 5.76e-03 | 18 | 119 | 2 | IPR002928 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.76e-03 | 18 | 119 | 2 | IPR008930 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 4.66e-05 | 32 | 89 | 4 | MM15290 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 PHLDB3 TFEB CHMP6 OFD1 MYCBP2 KIF26A PPRC1 LAD1 LAMB2 LAMB3 BCR TFE3 PPP1R26 PHLDB1 DEF6 OSBPL5 ZNF398 MAP3K11 PLEC HECTD1 GCN1 | 6.82e-11 | 1105 | 125 | 22 | 35748872 |
| Pubmed | 8.98e-11 | 98 | 125 | 9 | 18557763 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYCBP2 TNIP2 DBNL LAMB2 N4BP3 CXXC1 SPTBN4 ARHGAP22 PHLDB1 CEP89 HGS SAFB2 JAKMIP1 PSPC1 HOMER3 | 1.88e-09 | 560 | 125 | 15 | 21653829 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TCF3 TCF12 RIPK1 OFD1 MYCBP2 TUT7 GGCX G3BP1 MYH14 DNAJC11 GIGYF2 JAKMIP1 HECTD1 GCN1 PBXIP1 GPRASP2 CUX1 | 1.95e-09 | 754 | 125 | 17 | 33060197 |
| Pubmed | EHBP1 RIPK1 KIF26A LAMB2 EVPL RMDN3 HGS MAP3K11 GIGYF2 C4A PLEC GCN1 CUX1 | 2.44e-08 | 486 | 125 | 13 | 20936779 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EHBP1 TFEB ATG16L1 TCF3 TCF12 RIPK1 TNIP2 CAVIN3 N4BP3 BCR TFE3 PHLDB1 TFPT SLC7A6OS DNAJC11 MITF GIGYF2 AMOTL2 | 3.62e-08 | 1038 | 125 | 18 | 26673895 |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 14653779 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 1720355 | ||
| Pubmed | Expression of the proneural gene encoding Mash1 suppresses MYCN mitotic activity. | 4.53e-08 | 3 | 125 | 3 | 19208763 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 32881934 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 10768861 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 TFEB OFD1 MYCBP2 DBNL CAMSAP3 DNM1L N4BP3 BCR PHLDB1 CEP89 GIGYF2 PLEKHM3 PLEC HECTD1 CCDC102A | 8.76e-08 | 861 | 125 | 16 | 36931259 |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 11930005 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 10036191 | ||
| Pubmed | 3.29e-07 | 40 | 125 | 5 | 33591268 | ||
| Pubmed | 3.65e-07 | 17 | 125 | 4 | 29299163 | ||
| Pubmed | 4.48e-07 | 189 | 125 | 8 | 31594818 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 28165011 | ||
| Pubmed | Sumoylation of MITF and its related family members TFE3 and TFEB. | 4.51e-07 | 5 | 125 | 3 | 15507434 | |
| Pubmed | MICAL1 DBNL CAMSAP3 DNM1L BCR SPTBN4 CRACD PHLDB1 SAFB G3BP1 MYH14 C4A C4B PLEC CROCC TNNT2 PSPC1 PBXIP1 HOMER3 | 8.90e-07 | 1431 | 125 | 19 | 37142655 | |
| Pubmed | RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. | 8.99e-07 | 6 | 125 | 3 | 31101885 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TUT7 ABT1 DDX51 ZCCHC17 CACTIN RPUSD4 SAFB G3BP1 SLTM SAFB2 GIGYF2 PSPC1 GCN1 SF3A2 | 1.33e-06 | 807 | 125 | 14 | 22681889 |
| Pubmed | MYCN TFEB TCF12 TUT7 IKBKG ABT1 CXXC1 ATF6B TFAP4 TFE3 SLTM ZNF398 ZNF282 CUX1 | 1.35e-06 | 808 | 125 | 14 | 20412781 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.42e-06 | 298 | 125 | 9 | 32353859 | |
| Pubmed | Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. | 1.57e-06 | 7 | 125 | 3 | 18212736 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | MICAL1 ATG16L1 TUT7 DBNL ZCCHC17 CACTIN RPUSD4 SAFB DEF6 SLTM SAFB2 PLEC GCN1 | 1.57e-06 | 701 | 125 | 13 | 30196744 |
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | ISYNA1 TCF12 PGBD1 OAS1 CCND2 TFPT NDUFAF4 HGS TRAF3IP3 AMOTL2 HOMER3 GPRASP2 | 1.57e-06 | 590 | 125 | 12 | 25910212 |
| Pubmed | TCF12 RIPK1 LAD1 LAMB3 MISP3 ABT1 CRACD G3BP1 MYH14 JAKMIP1 PLEC | 2.19e-06 | 503 | 125 | 11 | 36217030 | |
| Pubmed | EVPL ABT1 DDX51 TFAP4 SAFB G3BP1 MYH14 SLTM SAFB2 GIGYF2 C4A PSPC1 SF3A2 CUX1 | 2.34e-06 | 847 | 125 | 14 | 35850772 | |
| Pubmed | The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. | 2.50e-06 | 8 | 125 | 3 | 9806910 | |
| Pubmed | EHBP1 MYCBP2 CAMSAP3 IKBKG BCR GIGYF2 PLEC GCN1 GPRASP2 CUX1 | 2.93e-06 | 418 | 125 | 10 | 34709266 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 N4BP3 BCR TFAP4 YOD1 TFPT SAFB G3BP1 GIGYF2 PLEC SCLT1 HECTD1 GCN1 SF3A2 GPRASP2 | 3.47e-06 | 1005 | 125 | 15 | 19615732 |
| Pubmed | MYCBP2 PPRC1 ZNF365 SPTBN4 MYH14 ASCL1 MAP3K11 JAKMIP1 PLEC AMOTL2 CADPS2 ZNHIT1 HECTD1 PBXIP1 SF3A2 GPRASP2 CUX1 | 3.72e-06 | 1285 | 125 | 17 | 35914814 | |
| Pubmed | 3.75e-06 | 9 | 125 | 3 | 8948587 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHMP6 OFD1 MYCBP2 LAMB2 PHLDB1 SAFB G3BP1 MYH14 SLTM SAFB2 GIGYF2 PLEC PSPC1 GCN1 SF3A2 | 4.34e-06 | 1024 | 125 | 15 | 24711643 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | MYCN TFEB TCF12 PTF1A ATF6B TFAP4 TFE3 HOXC12 ASCL1 ZNF282 CUX1 | 4.62e-06 | 544 | 125 | 11 | 28473536 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.73e-06 | 361 | 125 | 9 | 26167880 | |
| Pubmed | EHBP1 DBNL DNM1L GGCX CEMIP2 RMDN3 GIGYF2 CROCC GCN1 PBXIP1 CUX1 | 6.93e-06 | 568 | 125 | 11 | 37774976 | |
| Pubmed | 9.74e-06 | 12 | 125 | 3 | 18029035 | ||
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | IKBKG ZCCHC17 USH1C TFPT HGS CCDC120 AMOTL2 HOMER3 GPRASP2 CCDC85B | 1.04e-05 | 483 | 125 | 10 | 27107014 |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.07e-05 | 137 | 125 | 6 | 37039823 | |
| Pubmed | Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus. | 1.28e-05 | 2 | 125 | 2 | 28258196 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.28e-05 | 2 | 125 | 2 | 16565498 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15998580 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.28e-05 | 2 | 125 | 2 | 19933335 | |
| Pubmed | Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. | 1.28e-05 | 2 | 125 | 2 | 25048860 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18093538 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.28e-05 | 2 | 125 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.28e-05 | 2 | 125 | 2 | 17645767 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12207352 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 14587024 | ||
| Pubmed | TFEB and TFE3: The art of multi-tasking under stress conditions. | 1.28e-05 | 2 | 125 | 2 | 27892768 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.28e-05 | 2 | 125 | 2 | 27758680 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22387014 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34148064 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 10958665 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20154672 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.28e-05 | 2 | 125 | 2 | 23749435 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23918728 | ||
| Pubmed | E2A promotes the survival of precursor and mature B lymphocytes. | 1.28e-05 | 2 | 125 | 2 | 16888011 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.28e-05 | 2 | 125 | 2 | 3037333 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11726230 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.28e-05 | 2 | 125 | 2 | 6950384 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.28e-05 | 2 | 125 | 2 | 8428773 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.28e-05 | 2 | 125 | 2 | 21345967 | |
| Pubmed | E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. | 1.28e-05 | 2 | 125 | 2 | 17442955 | |
| Pubmed | TFEB/3 Govern Repair Schwann Cell Generation and Function Following Peripheral Nerve Injury. | 1.28e-05 | 2 | 125 | 2 | 39054068 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 2572548 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 2302180 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22151770 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12039954 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.28e-05 | 2 | 125 | 2 | 18091514 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29080553 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.28e-05 | 2 | 125 | 2 | 25339671 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17728371 | ||
| Pubmed | Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. | 1.28e-05 | 2 | 125 | 2 | 16766266 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 6149580 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 6149581 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12115608 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 3542363 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 2387317 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16908004 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 7365238 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 7391573 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.28e-05 | 2 | 125 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.28e-05 | 2 | 125 | 2 | 17971229 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 6881182 | ||
| Pubmed | Correlation between circulating innate lymphoid cell precursors and thymic function. | 1.28e-05 | 2 | 125 | 2 | 35118353 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.28e-05 | 2 | 125 | 2 | 17921792 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.28e-05 | 2 | 125 | 2 | 6978711 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35898513 | ||
| Pubmed | BMP-2 decreases Mash1 stability by increasing Id1 expression. | 1.28e-05 | 2 | 125 | 2 | 15318167 | |
| Interaction | YWHAH interactions | EHBP1 TFEB ATG16L1 EVC2 OFD1 MYCBP2 DBNL CAMSAP3 DNM1L N4BP3 BCR TFE3 RMDN3 PHLDB1 G3BP1 CEP89 CBY1 MITF OSBPL5 GIGYF2 PLEKHM3 JAKMIP1 PLEC AMOTL2 HECTD1 HOMER3 | 2.16e-09 | 1102 | 123 | 26 | int:YWHAH |
| Interaction | YWHAG interactions | MYCN EHBP1 TFEB ATG16L1 MYCBP2 TNIP2 DBNL CAMSAP3 DNM1L N4BP3 BCR TFE3 RMDN3 CRACD PHLDB1 CEP89 CBY1 MITF GIGYF2 PLEKHM3 JAKMIP1 AMOTL2 HECTD1 GPRASP2 CCDC102A | 1.16e-07 | 1248 | 123 | 25 | int:YWHAG |
| Interaction | YWHAB interactions | MYCN TFEB ATG16L1 MYCBP2 CAMSAP3 DNM1L N4BP3 BCR TFE3 RMDN3 PHLDB1 G3BP1 CEP89 CBY1 HGS MITF GIGYF2 PLEKHM3 JAKMIP1 AMOTL2 HECTD1 GPRASP2 | 1.95e-07 | 1014 | 123 | 22 | int:YWHAB |
| Interaction | RCOR1 interactions | EHBP1 PHLDB3 TCF3 MYCBP2 CAMSAP3 IKBKG LAMB2 BCR TFPT GIGYF2 PLEC SCLT1 GCN1 GPRASP2 CUX1 | 3.47e-07 | 494 | 123 | 15 | int:RCOR1 |
| Interaction | ATG16L1 interactions | TFEB MICAL1 ATG16L1 OFD1 MYCBP2 TUT7 DBNL IKBKG ZCCHC17 NLRP6 CACTIN RPUSD4 PHLDB1 SAFB CEP89 DEF6 MITF SLTM SAFB2 TRAF3IP3 PLEC GCN1 CCDC102A | 4.93e-07 | 1161 | 123 | 23 | int:ATG16L1 |
| Interaction | TOP3B interactions | VWA5B2 MYCN PHLDB3 TFEB CHMP6 OFD1 MYCBP2 KIF26A PPRC1 LAD1 LAMB2 LAMB3 BCR TFE3 PPP1R26 PHLDB1 SAFB G3BP1 DEF6 OSBPL5 SAFB2 ZNF398 MAP3K11 PLEC HECTD1 GCN1 | 6.90e-07 | 1470 | 123 | 26 | int:TOP3B |
| Interaction | KDM1A interactions | MYCN EHBP1 PHLDB3 ATG16L1 TCF3 OFD1 MYCBP2 CAMSAP3 IKBKG ZCCHC17 BCR GIGYF2 PLEC SCLT1 TNNT2 PSPC1 GCN1 HOMER3 GPRASP2 CUX1 | 1.04e-06 | 941 | 123 | 20 | int:KDM1A |
| Interaction | YWHAE interactions | MYCN TFEB ATG16L1 MYCBP2 TNIP2 DBNL CAMSAP3 DNM1L N4BP3 BCR TFE3 RMDN3 CRACD PHLDB1 G3BP1 CEP89 CBY1 GIGYF2 PLEKHM3 JAKMIP1 AMOTL2 HECTD1 HOMER3 | 1.91e-06 | 1256 | 123 | 23 | int:YWHAE |
| Interaction | FCHSD2 interactions | 2.81e-06 | 65 | 123 | 6 | int:FCHSD2 | |
| Interaction | NHLRC2 interactions | TBXAS1 TFEB RIPK1 OFD1 DNM1L SPTBN4 YOD1 DEF6 SAFB2 C4A SCLT1 HOMER3 | 3.25e-06 | 375 | 123 | 12 | int:NHLRC2 |
| Interaction | FXR1 interactions | MYCN ATG16L1 MYCBP2 N4BP3 ATF6B ARHGAP22 HABP4 PHLDB1 G3BP1 CEP89 SAFB2 GIGYF2 JAKMIP1 PSPC1 HECTD1 HOMER3 | 3.84e-06 | 679 | 123 | 16 | int:FXR1 |
| Interaction | CEP170 interactions | MYCN ATG16L1 OFD1 EMILIN1 TFPT CEP89 CBY1 CCDC120 SCLT1 PSPC1 HECTD1 | 4.07e-06 | 318 | 123 | 11 | int:CEP170 |
| Interaction | TANK interactions | 7.23e-06 | 216 | 123 | 9 | int:TANK | |
| Interaction | CCDC138 interactions | 1.05e-05 | 123 | 123 | 7 | int:CCDC138 | |
| Interaction | HAND1 interactions | 1.28e-05 | 24 | 123 | 4 | int:HAND1 | |
| Interaction | YWHAQ interactions | MYCN TFEB ATG16L1 TCF3 MYCBP2 CAMSAP3 DNM1L N4BP3 BCR TFE3 RMDN3 PHLDB1 G3BP1 CEP89 CBY1 PLEKHM3 PLEC AMOTL2 HECTD1 GCN1 | 1.38e-05 | 1118 | 123 | 20 | int:YWHAQ |
| Interaction | SAFB interactions | 1.91e-05 | 244 | 123 | 9 | int:SAFB | |
| Interaction | PNMA2 interactions | CAMSAP3 N4BP3 BCR ZNF783 RPUSD4 SAFB2 GIGYF2 ZNF282 CCDC102A | 2.39e-05 | 251 | 123 | 9 | int:PNMA2 |
| Interaction | LINC02910 interactions | 2.55e-05 | 95 | 123 | 6 | int:LINC02910 | |
| Interaction | SRPK2 interactions | MYCN ATG16L1 MYCBP2 TNIP2 DDX51 ZCCHC17 GGCX CACTIN PHLDB1 SAFB SLTM CADPS2 PSPC1 HECTD1 HOMER3 | 3.18e-05 | 717 | 123 | 15 | int:SRPK2 |
| Interaction | ZNF638 interactions | 3.25e-05 | 261 | 123 | 9 | int:ZNF638 | |
| Interaction | TPM1 interactions | 3.45e-05 | 263 | 123 | 9 | int:TPM1 | |
| Interaction | DEF6 interactions | 3.53e-05 | 61 | 123 | 5 | int:DEF6 | |
| Interaction | NEUROG3 interactions | 3.64e-05 | 149 | 123 | 7 | int:NEUROG3 | |
| Interaction | HDAC1 interactions | ANKRD13B MYCN EHBP1 ATG16L1 MYCBP2 CAMSAP3 IKBKG BCR TFAP4 TFE3 G3BP1 MYH14 GIGYF2 PLEC CROCC HECTD1 GCN1 GPRASP2 CUX1 | 4.16e-05 | 1108 | 123 | 19 | int:HDAC1 |
| Interaction | NUP62 interactions | 4.61e-05 | 273 | 123 | 9 | int:NUP62 | |
| Interaction | YWHAZ interactions | MYCN TFEB ATG16L1 MYCBP2 CAMSAP3 DNM1L N4BP3 BCR TFE3 RMDN3 CRACD PHLDB1 CEP89 CBY1 MAP3K11 GIGYF2 PLEKHM3 JAKMIP1 PLEC HECTD1 HOMER3 | 4.63e-05 | 1319 | 123 | 21 | int:YWHAZ |
| Interaction | IFI27L1 interactions | 4.81e-05 | 65 | 123 | 5 | int:IFI27L1 | |
| Interaction | PHF21A interactions | EHBP1 PHLDB3 MYCBP2 IKBKG BCR TFPT GIGYF2 PLEC SCLT1 GPRASP2 | 4.90e-05 | 343 | 123 | 10 | int:PHF21A |
| Interaction | ANKRD50 interactions | 5.27e-05 | 108 | 123 | 6 | int:ANKRD50 | |
| Interaction | SRBD1 interactions | 5.84e-05 | 110 | 123 | 6 | int:SRBD1 | |
| Interaction | RSBN1 interactions | 5.96e-05 | 161 | 123 | 7 | int:RSBN1 | |
| Interaction | KRT222 interactions | 5.98e-05 | 35 | 123 | 4 | int:KRT222 | |
| Interaction | MRFAP1L1 interactions | 6.45e-05 | 112 | 123 | 6 | int:MRFAP1L1 | |
| Interaction | CCDC59 interactions | 6.45e-05 | 112 | 123 | 6 | int:CCDC59 | |
| Interaction | FXR2 interactions | MYCN TNIP2 ZCCHC17 HABP4 PHLDB1 G3BP1 AMOTL2 PSPC1 HECTD1 HOMER3 CCDC85B | 6.64e-05 | 430 | 123 | 11 | int:FXR2 |
| Interaction | RTRAF interactions | 6.64e-05 | 222 | 123 | 8 | int:RTRAF | |
| Interaction | DCTN2 interactions | 6.68e-05 | 356 | 123 | 10 | int:DCTN2 | |
| Interaction | TRIM27 interactions | ATG16L1 TCF3 RIPK1 TNIP2 OAS1 ABT1 ARHGAP22 TFPT ASCL1 HGS AMOTL2 TSGA10IP | 7.37e-05 | 514 | 123 | 12 | int:TRIM27 |
| Interaction | HNRNPDL interactions | 8.03e-05 | 364 | 123 | 10 | int:HNRNPDL | |
| Interaction | SNRPC interactions | MYCN ATG16L1 OFD1 PPRC1 TNIP2 CACTIN HABP4 SAFB SAFB2 GIGYF2 SF3A2 | 8.15e-05 | 440 | 123 | 11 | int:SNRPC |
| Interaction | NDE1 interactions | 8.23e-05 | 117 | 123 | 6 | int:NDE1 | |
| Interaction | SFN interactions | TCF3 MYCBP2 LAD1 CAMSAP3 DNM1L N4BP3 BCR TFE3 PHLDB1 G3BP1 CEP89 CBY1 PLEC HECTD1 | 8.48e-05 | 692 | 123 | 14 | int:SFN |
| Interaction | TUT7 interactions | 8.63e-05 | 118 | 123 | 6 | int:TUT7 | |
| Interaction | KRT38 interactions | 9.03e-05 | 172 | 123 | 7 | int:KRT38 | |
| Interaction | TFEC interactions | 9.57e-05 | 15 | 123 | 3 | int:TFEC | |
| Interaction | PSMD9 interactions | 1.04e-04 | 176 | 123 | 7 | int:PSMD9 | |
| Interaction | FMR1 interactions | MYCN ATG16L1 MYCBP2 TNIP2 HABP4 G3BP1 SAFB2 GIGYF2 PSPC1 HECTD1 HOMER3 CUX1 | 1.09e-04 | 536 | 123 | 12 | int:FMR1 |
| Interaction | BAG2 interactions | VWA5B2 MYCN TFEB EVC2 RIPK1 OFD1 TNIP2 DBNL LAMB3 CXXC1 DNAJC11 HGS SF3A2 | 1.12e-04 | 622 | 123 | 13 | int:BAG2 |
| Interaction | ARMC8 interactions | 1.14e-04 | 240 | 123 | 8 | int:ARMC8 | |
| Interaction | CSNK1A1 interactions | MYCN ATG16L1 MYCBP2 IKBKG BCR ARHGAP22 HABP4 CBY1 GCN1 SF3A2 | 1.17e-04 | 381 | 123 | 10 | int:CSNK1A1 |
| Interaction | PTF1A interactions | 1.17e-04 | 16 | 123 | 3 | int:PTF1A | |
| Interaction | ZNF767P interactions | 1.17e-04 | 16 | 123 | 3 | int:ZNF767P | |
| Interaction | TP53BP2 interactions | 1.18e-04 | 241 | 123 | 8 | int:TP53BP2 | |
| Interaction | DOT1L interactions | MYCN EVPL ABT1 DDX51 TFAP4 SAFB G3BP1 MYH14 SLTM SAFB2 GIGYF2 C4A PSPC1 SF3A2 CUX1 | 1.20e-04 | 807 | 123 | 15 | int:DOT1L |
| Interaction | INO80E interactions | 1.23e-04 | 79 | 123 | 5 | int:INO80E | |
| Interaction | EXOSC7 interactions | 1.29e-04 | 127 | 123 | 6 | int:EXOSC7 | |
| Interaction | CBLN4 interactions | 1.29e-04 | 127 | 123 | 6 | int:CBLN4 | |
| Interaction | CCDC14 interactions | 1.41e-04 | 129 | 123 | 6 | int:CCDC14 | |
| Interaction | ELAVL2 interactions | 1.57e-04 | 188 | 123 | 7 | int:ELAVL2 | |
| Interaction | GAN interactions | 1.64e-04 | 253 | 123 | 8 | int:GAN | |
| Interaction | DNMT1 interactions | 1.69e-04 | 254 | 123 | 8 | int:DNMT1 | |
| Interaction | NUP54 interactions | 1.88e-04 | 136 | 123 | 6 | int:NUP54 | |
| Interaction | CCDC8 interactions | CHMP6 OFD1 MYCBP2 LAMB2 EMILIN1 PHLDB1 G3BP1 MYH14 GIGYF2 PLEC HECTD1 GCN1 GPRASP2 | 1.89e-04 | 656 | 123 | 13 | int:CCDC8 |
| Interaction | LTV1 interactions | 2.03e-04 | 196 | 123 | 7 | int:LTV1 | |
| Interaction | PALS1 interactions | 2.15e-04 | 89 | 123 | 5 | int:PALS1 | |
| Interaction | RALBP1 interactions | 2.16e-04 | 198 | 123 | 7 | int:RALBP1 | |
| Interaction | GIT2 interactions | 2.20e-04 | 140 | 123 | 6 | int:GIT2 | |
| Interaction | HSPA4 interactions | MYCN ATG16L1 OFD1 TNIP2 IKBKG DNM1L BCR TFE3 G3BP1 MYH14 MAP3K11 SCLT1 HECTD1 | 2.22e-04 | 667 | 123 | 13 | int:HSPA4 |
| Interaction | KIFC1 interactions | 2.51e-04 | 92 | 123 | 5 | int:KIFC1 | |
| Interaction | RABGEF1 interactions | 2.59e-04 | 204 | 123 | 7 | int:RABGEF1 | |
| Interaction | IFT57 interactions | 2.64e-04 | 93 | 123 | 5 | int:IFT57 | |
| Interaction | TFEB interactions | 2.85e-04 | 52 | 123 | 4 | int:TFEB | |
| Interaction | MIS18A interactions | 3.06e-04 | 96 | 123 | 5 | int:MIS18A | |
| Interaction | SDCCAG8 interactions | 3.14e-04 | 22 | 123 | 3 | int:SDCCAG8 | |
| Interaction | SAA1 interactions | 3.30e-04 | 54 | 123 | 4 | int:SAA1 | |
| Interaction | DPM2 interactions | 3.30e-04 | 54 | 123 | 4 | int:DPM2 | |
| Interaction | CCDC86 interactions | 3.31e-04 | 151 | 123 | 6 | int:CCDC86 | |
| Interaction | GOLGA6L9 interactions | 3.66e-04 | 216 | 123 | 7 | int:GOLGA6L9 | |
| Interaction | ZNRD2 interactions | 3.93e-04 | 288 | 123 | 8 | int:ZNRD2 | |
| Interaction | SLU7 interactions | 3.94e-04 | 156 | 123 | 6 | int:SLU7 | |
| Interaction | EIF2D interactions | 4.06e-04 | 57 | 123 | 4 | int:EIF2D | |
| Interaction | DDX21 interactions | MYCN TUT7 DNM1L ABT1 DDX51 ZCCHC17 TFE3 SAFB G3BP1 SLTM SAFB2 PSPC1 HECTD1 | 4.48e-04 | 718 | 123 | 13 | int:DDX21 |
| Interaction | TFPT interactions | 4.51e-04 | 160 | 123 | 6 | int:TFPT | |
| Interaction | SRSF9 interactions | 4.55e-04 | 224 | 123 | 7 | int:SRSF9 | |
| Interaction | TCF3 interactions | 4.61e-04 | 295 | 123 | 8 | int:TCF3 | |
| Interaction | MAGED1 interactions | 4.61e-04 | 295 | 123 | 8 | int:MAGED1 | |
| Interaction | NCKAP5L interactions | 4.84e-04 | 106 | 123 | 5 | int:NCKAP5L | |
| Interaction | ACIN1 interactions | 5.27e-04 | 301 | 123 | 8 | int:ACIN1 | |
| Interaction | CENPQ interactions | 5.27e-04 | 108 | 123 | 5 | int:CENPQ | |
| Interaction | PNN interactions | 5.38e-04 | 302 | 123 | 8 | int:PNN | |
| Interaction | ID3 interactions | 5.61e-04 | 62 | 123 | 4 | int:ID3 | |
| Interaction | AIM2 interactions | 5.73e-04 | 110 | 123 | 5 | int:AIM2 | |
| Interaction | INO80D interactions | 5.83e-04 | 27 | 123 | 3 | int:INO80D | |
| Interaction | ISG20L2 interactions | 5.96e-04 | 63 | 123 | 4 | int:ISG20L2 | |
| Interaction | GPATCH1 interactions | 5.97e-04 | 111 | 123 | 5 | int:GPATCH1 | |
| Interaction | CCDC136 interactions | 6.02e-04 | 169 | 123 | 6 | int:CCDC136 | |
| Interaction | DDX55 interactions | 6.02e-04 | 169 | 123 | 6 | int:DDX55 | |
| Interaction | ZC3H14 interactions | 6.02e-04 | 169 | 123 | 6 | int:ZC3H14 | |
| Interaction | NGRN interactions | 6.05e-04 | 235 | 123 | 7 | int:NGRN | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | TCF3 ISYNA1 CAMSAP3 MISP3 CACTIN SAFB SAFB2 HOMER3 SF3A2 ZNF433 | 6.94e-05 | 797 | 125 | 10 | chr19p13 |
| Cytoband | 1q32 | 3.31e-04 | 49 | 125 | 3 | 1q32 | |
| Cytoband | 12q24.2 | 8.61e-04 | 16 | 125 | 2 | 12q24.2 | |
| Cytoband | 7q36.1 | 1.11e-03 | 74 | 125 | 3 | 7q36.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 1.23e-03 | 290 | 125 | 5 | chr1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 3.27e-03 | 222 | 125 | 4 | chr4p16 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.48e-09 | 110 | 81 | 9 | 420 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | PHLDB3 BCR SPTBN4 ARHGAP22 PHLDB1 DEF6 OSBPL5 PLEKHM3 CADPS2 | 3.49e-07 | 206 | 81 | 9 | 682 |
| GeneFamily | RNA binding motif containing | 3.88e-04 | 213 | 81 | 6 | 725 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.45e-04 | 8 | 81 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.99e-04 | 9 | 81 | 2 | 1234 | |
| GeneFamily | Laminin subunits | 1.27e-03 | 12 | 81 | 2 | 626 | |
| GeneFamily | INO80 complex |SRCAP complex | 2.00e-03 | 15 | 81 | 2 | 595 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 5.56e-03 | 25 | 81 | 2 | 74 | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.34e-06 | 195 | 125 | 9 | 4784_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 1.52e-06 | 198 | 125 | 9 | 7076_UP | |
| Drug | AC1L4GYE | 3.19e-06 | 6 | 125 | 3 | CID000156861 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 1.21e-05 | 194 | 125 | 8 | 433_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.30e-05 | 196 | 125 | 8 | 4826_DN | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 3.62e-05 | 16 | 121 | 3 | DOID:3211 (implicated_via_orthology) | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 4.99e-05 | 3 | 121 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | liver cancer (is_implicated_in) | 1.65e-04 | 5 | 121 | 2 | DOID:3571 (is_implicated_in) | |
| Disease | Orofaciodigital Syndromes | 2.47e-04 | 6 | 121 | 2 | C0029294 | |
| Disease | MiT family translocation renal cell carcinoma | 3.46e-04 | 7 | 121 | 2 | C4518356 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 7.36e-04 | 43 | 121 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.08e-03 | 49 | 121 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Necrosis | 1.51e-03 | 55 | 121 | 3 | C0027540 | |
| Disease | platelet measurement | 1.94e-03 | 315 | 121 | 6 | EFO_0005036 | |
| Disease | Child Behaviour Checklist assessment | 2.44e-03 | 18 | 121 | 2 | EFO_0005661 | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.89e-03 | 69 | 121 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | Lupus Erythematosus, Systemic | 3.14e-03 | 71 | 121 | 3 | C0024141 | |
| Disease | mean platelet volume | MICAL1 TCF12 DNM1L EPX TFAP4 SVEP1 NLRP6 HABP4 MAP3K11 PLEC CUX1 | 3.21e-03 | 1020 | 121 | 11 | EFO_0004584 |
| Disease | Precursor B-cell lymphoblastic leukemia | 3.33e-03 | 21 | 121 | 2 | C1292769 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RERLAEARQRELQRQ | 301 | Q9Y6N9 | |
| AVLRENARLQRDNER | 316 | Q9Y2J4 | |
| NRDLRERLESANRRL | 391 | Q9Y2J4 | |
| QERAVRRAAQVQRLE | 96 | Q969G5 | |
| LNRRLQAENRELRDL | 66 | Q15834 | |
| LQLFEGRRNRRRREA | 1441 | P0C0L5 | |
| NIEEQRRNRLARELP | 511 | O00429 | |
| SIRRLEQEVNQERFR | 41 | P11274 | |
| LRRRDRLQRQAFEEI | 21 | Q676U5 | |
| RREVQRLRRRNQQLE | 71 | Q9Y3M2 | |
| QLRRLQELNARRREE | 301 | Q9H9F9 | |
| RIAQQLERERALARQ | 36 | Q96FZ7 | |
| QRRAQLQERLEAARE | 211 | A6NFT4 | |
| LLERQQRRAEEARRR | 906 | Q9P1Y5 | |
| RRQSNLQEVLERERR | 896 | O75665 | |
| AQQLEQIRRDIRDFR | 201 | Q9NPH2 | |
| QALELADEARRRRQF | 296 | Q5VVQ6 | |
| RDRNLLRDDRVLQNL | 16 | P30279 | |
| LSAQEQEERRRRARQ | 596 | Q86YJ7 | |
| LQRRAQAAQEEQRRR | 446 | D6REC4 | |
| DERVQQLRRRISERA | 571 | D6REC4 | |
| ELERSRERRLQALQQ | 686 | D6REC4 | |
| REQEQRRLSQERDRL | 176 | Q6NSJ2 | |
| RRLSQERDRLEGLRQ | 181 | Q6NSJ2 | |
| EFERLQREREERRLQ | 106 | Q9NVH1 | |
| QREREERRLQQRTNP | 111 | Q9NVH1 | |
| NEFITRQRRRELSDR | 236 | P31275 | |
| TRQERRQRRQVVEAA | 91 | O00515 | |
| RFRARNQELEAENRL | 511 | Q13948 | |
| EQRRRRRQVQADALR | 141 | Q96HB5 | |
| QLEAQRAEAERLRQR | 216 | Q9NSC5 | |
| ILREAERRRQQQLQR | 41 | Q5JVS0 | |
| RRRLELQLQEVQGRA | 1271 | Q7Z406 | |
| LVDELRDRLFRQVRR | 536 | P11678 | |
| RRRQLELEVQQLRAG | 1401 | Q92817 | |
| ANNARERLRVRDINE | 581 | Q99081 | |
| RRELLQKHREQRREQ | 676 | Q86UK5 | |
| LRDAIRQSNQILRER | 61 | Q9Y6K9 | |
| RRAEQLLQDARRARS | 1581 | P55268 | |
| LRLAERRQQRLREVQ | 1781 | Q9ULI4 | |
| VNQRDALIRFQEERR | 1041 | Q8TDZ2 | |
| AQLDREAQVRRRLQE | 836 | Q92616 | |
| RRAFDGERLRLQQEI | 141 | Q96N16 | |
| QLNRRGEFIQEIRRQ | 91 | P00973 | |
| QDVLRLRAETRQRAQ | 431 | Q6ZWE6 | |
| VEHDRRRRQFTVRLN | 21 | Q8N6N6 | |
| LQQLRQAANVRERRR | 161 | Q7RTS3 | |
| RQEERLREQNLRALE | 41 | Q8TB68 | |
| AFERQVRRQRLRAEV | 161 | Q9ULW3 | |
| RVRRELERSHRQLEQ | 656 | Q5TZA2 | |
| LREFLQELRSAQRER | 1511 | Q5TZA2 | |
| ERIRREQQSARTRLQ | 431 | Q9P0U4 | |
| EANLRRQRRLVRSQV | 1256 | Q9ULT8 | |
| RQREQEIALRRQREE | 796 | Q6Y7W6 | |
| QPAAVARRNERERNR | 116 | P50553 | |
| ERLQSRARERQQQRE | 36 | Q8N8A6 | |
| FRENRRIRELLQDTL | 726 | Q96ST8 | |
| RPQRDQRVREQRINI | 296 | Q13283 | |
| RRLEEQRLQALERRL | 246 | Q6ZU35 | |
| RRLQAQAQAEERRRL | 321 | Q6ZU35 | |
| VRAERNRAREEVRQL | 111 | Q96A19 | |
| NRAREEVRQLRQRLD | 116 | Q96A19 | |
| SFIEERRARENRLNQ | 231 | Q5T5S1 | |
| PQRQLDDEQERRIRL | 71 | Q86UW7 | |
| RNESRRLQEFLRFQD | 291 | Q9UHN6 | |
| RRLRNHERREIQREI | 41 | P22003 | |
| RLLQEEEERRRSQHR | 376 | Q9H4E7 | |
| QQDEERRRQLRERAR | 856 | Q8NDI1 | |
| QLRDSRREAERLVRQ | 741 | Q13751 | |
| QQQSLQERLRLREER | 136 | Q8WUQ7 | |
| GFRRQQQEDRERLRA | 311 | Q9Y6C2 | |
| TQTDRERERNTQRLR | 76 | Q08E93 | |
| YRRRRQQRQAETEER | 756 | Q5VV67 | |
| RRAEEAQRQLEQERR | 196 | Q9UJU6 | |
| AQRQLEQERRERELR | 201 | Q9UJU6 | |
| ERELREAARREQRYQ | 211 | Q9UJU6 | |
| RAAREQRSQAEQLRR | 426 | Q16584 | |
| RDVAAQLQERRLQRL | 91 | P59044 | |
| LQLFEGRRNRRRREA | 1441 | P0C0L4 | |
| LRRLEEQFRRFQEVT | 41 | Q96A99 | |
| FALEEAQRQRARERQ | 671 | Q9H0X9 | |
| RRVQEIVRFTRQLQR | 71 | Q96CM3 | |
| LLLAFLQRRQRRRQD | 226 | Q8TDU9 | |
| ERQRQEERQQAELRR | 391 | Q3SY00 | |
| EENQRVARRRRFPFV | 131 | Q96TC7 | |
| IRDRIQRRAEELRNT | 421 | Q9UQF0 | |
| NLIERRRRFNINDRI | 241 | P19484 | |
| NNLFRPRVREEANIR | 301 | Q96D09 | |
| EFLNRLNRFLEEERR | 101 | Q9UL41 | |
| RIAREREELRRQQQQ | 701 | Q9NWH9 | |
| REELRRQQQQLRYEQ | 706 | Q9NWH9 | |
| QLRQEEKRQRVIRRH | 856 | O75592 | |
| IRGIRNFNLENRAER | 6 | Q9P032 | |
| RYRRRVNRDDQEQDA | 1171 | Q5T8A7 | |
| QNLVRDAIRRDRFEL | 486 | Q96JS3 | |
| QNVAYNREEERRRRV | 401 | Q13546 | |
| QAFRRRVRLLRELSE | 66 | Q4LDE5 | |
| ESNRDRRERLRQLAL | 21 | Q15428 | |
| EIARERLAFQRQRLE | 646 | Q15424 | |
| RIHREREELRRQQEL | 686 | Q15424 | |
| RAREDAERRNQLLQR | 661 | Q7Z5H3 | |
| QLRRENAALRRRLEA | 366 | Q99941 | |
| DLQVRQDVRNRTLRA | 101 | Q8NCH0 | |
| VRRNLRASAREVRQE | 86 | Q96CW6 | |
| ALLEQVARFREQLRR | 66 | Q8NFZ5 | |
| RLQQFFRRRNLELEE | 61 | Q9Y228 | |
| RDQQAAEERRRDFLQ | 266 | P24557 | |
| RRQQRLQEIERRRNT | 661 | P38435 | |
| VQRRERALNRQVDVA | 211 | Q70YC5 | |
| NNVIIEQEERRRRSF | 101 | Q9NP64 | |
| VQRITRRLQQERRFL | 106 | P0C1Z6 | |
| VREREQELQRQRRSV | 161 | Q96FF7 | |
| HNLIERRRRFNINDR | 316 | O75030 | |
| AQALRQELERQRRLL | 391 | Q96AQ6 | |
| ERRRNHNILERQRRN | 381 | P04198 | |
| HNLIERRRRFNINDR | 351 | P19532 | |
| RVANNARERLRVRDI | 551 | P15923 | |
| RRQEELRRLEELRNQ | 326 | Q8WXF1 | |
| RRLENLENLLRNRNF | 111 | Q8TD17 | |
| RRAAEEAERQRQIQL | 496 | O14964 | |
| RAERAEQQRIRNERE | 141 | P45379 | |
| LRVEDRQDLNRQRIQ | 671 | Q9H1D0 | |
| QRLEEAAARRERRLQ | 756 | Q9H254 | |
| HREREELRRQQEQLR | 706 | Q14151 | |
| ELRRQQEQLRYEQER | 711 | Q14151 | |
| DFLREQNRRLNEDFR | 6 | Q96NL6 | |
| ERRLRQAEVERARQV | 1686 | Q15149 | |
| EYHRRQRQERLREQE | 591 | Q86UU1 | |
| VRARRDFQRLQRRDS | 296 | Q8N398 | |
| RAARQRRINRQLEAL | 21 | O43257 | |
| VRRRRDQEDALNQRY | 1366 | Q5VYS8 | |
| QDRRQEEDQRRFEPR | 111 | Q07283 | |
| ERREQQEERREQQLR | 326 | Q07283 | |
| REQEERREQQLRREQ | 341 | Q07283 | |
| RREQQLRREQEEERR | 346 | Q07283 | |
| ERREQQLRREQQLRR | 371 | Q07283 | |
| QLRREQQLRREQQLR | 376 | Q07283 | |
| REQQLRREQQLRREQ | 391 | Q07283 | |
| RREQQLRREQQLRRE | 396 | Q07283 | |
| LRREQQLRREQQLRR | 401 | Q07283 | |
| QLRREQQLRREQQLR | 406 | Q07283 | |
| ERREQQLRREQEERR | 501 | Q07283 | |
| ERLQQRLRSEQQLRR | 526 | Q07283 | |
| RLRSEQQLRREQEER | 531 | Q07283 | |
| QQLRREQEERREQLL | 536 | Q07283 | |
| REQRERQLRAEERQQ | 791 | Q07283 | |
| RQLRAEERQQREQRF | 796 | Q07283 | |
| LQEDQERRRSQEQRR | 856 | Q07283 | |
| RRRQEQERQYREEEQ | 921 | Q07283 | |
| FLEEEQRLRRQERER | 1376 | Q07283 | |
| EQQLRRQERDRKFRE | 1491 | Q07283 | |
| EQQLRRQERDRKFRE | 1681 | Q07283 | |
| RKFREEEQQLRRQER | 1691 | Q07283 | |
| EQQLRRQERDRKFRE | 1761 | Q07283 | |
| RLRQERDRQYRAEEQ | 1836 | Q07283 | |
| NLRRNLRIVGERLFE | 61 | Q8N7K0 | |
| QRDQERRIRREIANS | 41 | Q01664 | |
| RRLENLENLLRNRNF | 166 | Q9UDV7 | |
| RRLENVENLLRNRNF | 111 | Q6ZMS7 | |
| EQFRRLLTQENRRVT | 311 | P35573 | |
| RLRGQEQALRFEQER | 476 | O15049 | |
| RRNQALEQELRALRE | 516 | O15049 |